Trial intelligence / Profile preview

MATMA: Prazosin for Methamphetamine Abuse

NCT01178138Phase 2Completed

Sponsor
University of Arkansas
Start
Dec 2009
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of prazosin in methamphetamine use disorder (MUD), sponsored by University of Arkansas. Started Dec 2009; status: completed.

02

Drugs

prazosin
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on NCT01178138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01178138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call